CSIMarket Company Name, Ticker, Competitors, else..
 
Co diagnostics Inc   (NASDAQ: CODX)
 
Price: $1.1600 $0.00 0.000%
Day's High: $1.190000057220459 Week Perf: -6.45 %
Day's Low: $ 1.14 30 Day Perf: -18.31 %
Volume (M): 60,600 52 Wk High: $ 46.50
Volume (M$): $ 0 52 Wk Avg: $5.35
Open: $1.18 52 Wk Low: $0.94



 Market Capitalization (Millions $) 5
 Shares Outstanding (Millions) 4
 Employees 115
 Revenues (TTM) (Millions $) 1
 Net Income (TTM) (Millions $) -47
 Cash Flow (TTM) (Millions $) -3
 Capital Exp. (TTM) (Millions $) 0

Business Description


Co-Diagnostics Inc. is a molecular diagnostics company that develops and commercializes innovative testing solutions for a variety of industries. The company's core focus is on developing and manufacturing polymerase chain reaction (PCR) diagnostics for infectious diseases, liquid biopsy, and other molecular testing markets. Co-Diagnostics uses its proprietary technology to create high-quality and affordable tests that offer fast and accurate results. Their tests are designed to detect a wide range of pathogens and genetic markers, enabling early diagnosis and effective treatment. The company aims to provide reliable testing solutions that contribute to improved patient outcomes and public health.


   Company Address: 2401 S. Foothill Drive Salt Lake City 84109 UT
   Company Phone Number: 438-1036   Stock Exchange / Ticker: NASDAQ CODX


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
BIO   -0.41%    
BNGO        2.56% 
DGX   -2.32%    
JNJ        2.68% 
• View Complete Report
   



Products & Services

Co-Diagnostics, Inc. Launches New Manufacturing Facility in Utah, Receives Support from Local Dignitaries

Published Fri, Apr 12 2024 1:30 PM UTC

Reflecting the biotech industry s rapid growth in Utah, Co-Diagnostics, Inc., a prominent molecular diagnostics company, has unveiled a brand new manufacturing facility in Salt Lake City. On April 12, 2024, the organization celebrated this significant milestone with a grand ribbon-cutting event. The inauguration drew the attendance of several dignitaries, including Mayor Woo...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 6.93
Price to Sales (Expected) -
Price to Book 0.39
PEG (TTM) -

Financial Strength Current
Quick Ratio 2.55
Working Capital Ratio 3.09
Leverage Ratio (MRQ) 0.31
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -25.03 $
Revenues (TTM) 0.17 $
Cash Flow (TTM) -
Cash 1.69 $
Book Value 2.95 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 6,273
Net Income per Employee (TTM) -409,186
Receivable Turnover Ratio (TTM) 7.58
Inventory Turnover Ratio (TTM) 0.43
Asset Turnover Ratio (TTM) 0.03

Profitability Ratios Current
Gross Margin (MRQ) 72.73 %
Operating Margin (MRQ) -3732.47 %
Net Margin (MRQ) -3782.43 %
Net Cash Flow Margin (MRQ) 0 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Co Diagnostics Inc's Segments
Non-US Product    75.9 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.